CoChat

Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis

Montanari, Sara, Oliver, Antonio, Salerno, Paola, Mena, Ana, Bertoni, Giovanni, Tümmler, Burkhard, Cariani, Lisa, Conese, Massimo, Döring, Gerd, Bragonzi, Alessandra · 2007 · Microbiology
Cited by 87

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1099/mic.0.2006/003400-0

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 41

  1. Anthony, 2002, Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients, J Clin Microbiol, 40, 2772, 10.1128/JCM.40.8.2772-2778.2002 · DOI · Paper page
  2. Barth, 1996, The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa, J Med Microbiol, 45, 110, 10.1099/00222615-45-2-110 · DOI · Paper page
  3. Bragonzi, 2005, Non-mucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model, J Infect Dis, 192, 410, 10.1086/431516 · DOI
  4. Bragonzi, 2006, Sequence diversity of the mucABD locus in Pseudomonas aeruginosa isolates from patients with cystic fibrosis, Microbiology, 152, 3261, 10.1099/mic.0.29175-0 · DOI
  5. Burns, 2005, Hypermutability in CF pathogens, Pediatr Pulmonol Suppl, 28, 115
  6. Campoy, 2000, Virulence and mutation rates of Salmonella typhimurium strains with increased mutagenic strength in a mouse model, FEMS Microbiol Lett, 187, 145, 10.1111/j.1574-6968.2000.tb09151.x · doi:10.1111/j.1574-6968.2000.tb09151.x
  7. Cash, 1979, A rat model of chronic respiratory infection with Pseudomonas aeruginosa, Am Rev Respir Dis, 119, 453
  8. Ciofu, 2005, Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation, Antimicrob Agents Chemother, 49, 2276, 10.1128/AAC.49.6.2276-2282.2005 · DOI · Paper page
  9. 2005, Performance Standards for Antimicrobial Susceptibility Testing. Fifteenth informational supplement, M100-S15
  10. Deretic, 1995, Pseudomonas aeruginosa , mucoidy and the chronic infection phenotype in cystic fibrosis, Trends Microbiol, 3, 351, 10.1016/S0966-842X(00)88974-X · DOI
  11. Dinesh, 2003, European-wide distribution of Pseudomonas aeruginosa clone C, Clin Microbiol Infect, 9, 1228, 10.1111/j.1469-0691.2003.00793.x · DOI
  12. Friedberg, 1995, DNA Repair and Mutagenesis
  13. Funchain, 2000, The consequences of growth of a mutator strain of Escherichia coli as measured by loss of function among multiple gene targets and loss of fitness, Genetics, 154, 959, 10.1093/genetics/154.3.959 · DOI · Paper page
  14. Giraud, 2001, Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut, Science, 291, 2606, 10.1126/science.1056421 · DOI · Paper page
  15. Gutiérrez, 2004, Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients, Antimicrob Agents Chemother, 48, 3573, 10.1128/AAC.48.9.3573-3575.2004 · DOI · Paper page
  16. Häussler,, 1999, Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis, Clin Infect Dis, 29, 621, 10.1086/598644 · DOI · Paper page
  17. Hava, 2002, Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors, Mol Microbiol, 45, 1389
  18. Hogardt, 2006, Sequence variability and functional analysis of MutS of hypermutable Pseudomonas aeruginosa cystic fibrosis isolates, Int J Med Microbiol, 296, 313, 10.1016/j.ijmm.2005.12.018 · doi:10.1016/j.ijmm.2005.12.018
  19. LeClerc, 1996, High mutation frequencies among Escherichia coli and Salmonella pathogens, Science, 274, 1208, 10.1126/science.274.5290.1208 · DOI · Paper page
  20. Lee, 2006, Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial, Genome Biol, 7, R90, 10.1186/gb-2006-7-10-r90 · DOI · Paper page
  21. Luzar, 1985, Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition, Infect Immun, 50, 577, 10.1128/IAI.50.2.577-582.1985 · DOI
  22. Macia, 2005, Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections, Antimicrob Agents Chemother, 49, 3382, 10.1128/AAC.49.8.3382-3386.2005 · DOI · Paper page
  23. Macia, 2006, Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa, Antimicrob Agents Chemother, 50, 975, 10.1128/AAC.50.3.975-983.2006 · DOI
  24. Merino, 2002, A hypermutator phenotype attenuates the virulence of Listeria monocytogenes in a mouse model, Mol Microbiol, 44, 877, 10.1046/j.1365-2958.2002.02929.x · doi:10.1046/j.1365-2958.2002.02929.x
  25. Miller, 1996, Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair, Annu Rev Microbiol, 50, 625, 10.1146/annurev.micro.50.1.625 · DOI · Paper page
  26. Nilsson, 2004, Experimental adaptation of Salmonella typhimurium to mice, Genetics, 168, 1119, 10.1534/genetics.104.030304 · DOI
  27. Oliver, 2000, High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection, Science, 288, 1251, 10.1126/science.288.5469.1251 · DOI · Paper page
  28. Oliver, 2002, The mismatch repair system ( mutS , mutL and uvrD genes) in Pseudomonas aeruginosa : molecular characterization of naturally occurring mutants, Mol Microbiol, 43, 1641, 10.1046/j.1365-2958.2002.02855.x · DOI · Paper page
  29. Oliver, 2004, Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections, Antimicrob Agents Chemother, 48, 4226, 10.1128/AAC.48.11.4226-4233.2004 · DOI
  30. Potvin, 2003, In vivo functional genomics of Pseudomonas aeruginosa for high-throughput screening of new virulence factors and antibacterial targets, Environ Microbiol, 5, 1294, 10.1046/j.1462-2920.2003.00542.x · DOI · Paper page
  31. Prunier, 2003, High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains, J Infect Dis, 187, 1709, 10.1086/374937 · DOI · Paper page
  32. Radman, 2000, Evolution-driving genes, Res Microbiol, 151, 91, 10.1016/S0923-2508(00)00122-4 · DOI
  33. Ratjen, 2003, Cystic fibrosis, Lancet, 361, 681, 10.1016/S0140-6736(03)12567-6 · DOI · Paper page
  34. Roman, 2004, Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains, J Clin Microbiol, 42, 1450, 10.1128/JCM.42.4.1450-1459.2004 · DOI
  35. Römling, 1997, Large genome rearrangements discovered by the detailed analysis of 21 Pseudomonas aeruginosa clone C isolates found in environment and disease habitats, J Mol Biol, 271, 386, 10.1006/jmbi.1997.1186 · DOI
  36. Stover, 2000, Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen, Nature, 406, 959, 10.1038/35023079 · DOI · Paper page
  37. Taddei, 1997, Role of mutator alleles in adaptive evolution, Nature, 387, 700, 10.1038/42696 · DOI · Paper page
  38. Tümmler, 1991, Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients, J Clin Microbiol, 29, 1265, 10.1128/JCM.29.6.1265-1267.1991 · doi:10.1128/jcm.29.6.1265-1267.1991
  39. Watson, 2004, Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum, Microbiology, 150, 2947, 10.1099/mic.0.27230-0 · DOI
  40. Worlitzsch, 2002, Effects of reduced mucus oxygen concentration in airway Pseudomonas infection of cystic fibrosis patients, J Clin Invest, 109, 317, 10.1172/JCI0213870 · DOI · Paper page
  41. Zahrt, 1999, Effect of mutS and recD mutations on Salmonella virulence, Infect Immun, 67, 6168, 10.1128/IAI.67.11.6168-6172.1999 · doi:10.1128/iai.67.11.6168-6172.1999

Cited by

See all 87

Metadata

Authors
Montanari, S., Oliver, A., Salerno, P., Mena, A., Bertoni, G., Tümmler, B., Cariani, L., Conese, M., Döring, G., & Bragonzi, A.
Affiliations
  • Institute for Experimental Treatment of Cystic Fibrosis, Scientific Institute H. S. Raffaele, Milano, Italy
  • Servicio de Microbiologìa Hospital Son Dureta, Palma de Mallorca, Spain
  • Dipartimento di Scienze Biomolecolari e Biotecnologie, Università degli Studi di Milano, Milano, Italy
  • Klinische Forschergruppe, OE 6710, Medizinische Hochschule Hannover, Hannover, Germany
  • Ospedale Maggiore Policlinico, CF Clinic, Milano, Italy
  • Institute of Medical Microbiology and Hygiene, Universitätsklinikum Tübingen, Tübingen, Germany
Venue
Microbiology
Published
2007-05-01
Volume
153
Issue
5
Pages
1445-1454
ISSN
  • 1350-0872
  • 1465-2080
Cited by
87
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.